PMID- 22573867 OWN - NLM STAT- MEDLINE DCOM- 20120910 LR - 20211021 IS - 1098-5514 (Electronic) IS - 0022-538X (Print) IS - 0022-538X (Linking) VI - 86 IP - 14 DP - 2012 Jul TI - West Nile virus T-cell ligand sequences shared with other flaviviruses: a multitude of variant sequences as potential altered peptide ligands. PG - 7616-24 LID - 10.1128/JVI.00166-12 [doi] AB - Phylogenetic relatedness and cocirculation of several major human pathogen flaviviruses are recognized as a possible cause of deleterious immune responses to mixed infection or immunization and call for a greater understanding of the inter-Flavivirus protein homologies. This study focused on the identification of human leukocyte antigen (HLA)-restricted West Nile virus (WNV) T-cell ligands and characterization of their distribution in reported sequence data of WNV and other flaviviruses. H-2-deficient mice transgenic for either A2, A24, B7, DR2, DR3, or DR4 HLA alleles were immunized with overlapping peptides of the WNV proteome, and peptide-specific T-cell activation was measured by gamma interferon (IFN-gamma) enzyme-linked immunosorbent spot (ELISpot) assays. Approximately 30% (137) of the WNV proteome peptides were identified as HLA-restricted T-cell ligands. The majority of these ligands were conserved in approximately >/=88% of analyzed WNV sequences. Notably, only 51 were WNV specific, and the remaining 86, chiefly of E, NS3, and NS5, shared an identity of nine or more consecutive amino acids with sequences of 64 other flaviviruses, including several major human pathogens. Many of the shared ligands had an incidence of >50% in the analyzed sequences of one or more of six major flaviviruses. The multitude of WNV sequences shared with other flaviviruses as interspecies variants highlights the possible hazard of defective T-cell activation by altered peptide ligands in the event of dual exposure to WNV and other flaviviruses, by either infection or immunization. The data suggest the possible preferred use of sequences that are pathogen specific with minimum interspecies sequence homology for the design of Flavivirus vaccines. FAU - Jung, Keun-Ok AU - Jung KO AD - Department of Pharmacology and Molecular Sciences, The Johns Hopkins University School of Medicine, Baltimore, MD, USA. FAU - Khan, Asif M AU - Khan AM FAU - Tan, Benjamin Yong Liang AU - Tan BY FAU - Hu, Yongli AU - Hu Y FAU - Simon, Gregory G AU - Simon GG FAU - Nascimento, Eduardo J M AU - Nascimento EJ FAU - Lemonnier, Francois AU - Lemonnier F FAU - Brusic, Vladimir AU - Brusic V FAU - Miotto, Olivo AU - Miotto O FAU - Tan, Tin Wee AU - Tan TW FAU - Marques, Ernesto T A AU - Marques ET FAU - Dhalia, Rafael AU - Dhalia R FAU - Salmon, Jerome AU - Salmon J FAU - August, J Thomas AU - August JT LA - eng PT - Journal Article DEP - 20120509 PL - United States TA - J Virol JT - Journal of virology JID - 0113724 RN - 0 (Antigens, Viral) RN - 0 (Histocompatibility Antigens) RN - 0 (Ligands) RN - 0 (Proteome) RN - 0 (Viral Proteins) RN - 82115-62-6 (Interferon-gamma) SB - IM MH - Amino Acid Sequence MH - Animals MH - Antigens, Viral/*immunology MH - Enzyme-Linked Immunospot Assay MH - Flavivirus/*immunology MH - Genetic Variation MH - Histocompatibility Antigens/genetics/*immunology MH - Interferon-gamma MH - Ligands MH - *Lymphocyte Activation MH - Mice MH - Mice, Transgenic MH - Proteome MH - T-Lymphocytes/*immunology/metabolism MH - Viral Proteins/*immunology MH - West Nile virus/genetics/*immunology/metabolism PMC - PMC3416302 EDAT- 2012/05/11 06:00 MHDA- 2012/09/11 06:00 PMCR- 2013/01/01 CRDT- 2012/05/11 06:00 PHST- 2012/05/11 06:00 [entrez] PHST- 2012/05/11 06:00 [pubmed] PHST- 2012/09/11 06:00 [medline] PHST- 2013/01/01 00:00 [pmc-release] AID - JVI.00166-12 [pii] AID - 00166-12 [pii] AID - 10.1128/JVI.00166-12 [doi] PST - ppublish SO - J Virol. 2012 Jul;86(14):7616-24. doi: 10.1128/JVI.00166-12. Epub 2012 May 9.